-
Uncategorized4 weeks agoSTAT+: A political contest in the U.K. could shake up drug pricing
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Congrats on making...
-
Uncategorized4 weeks ago
Biogen’s Alzheimer’s results bolster tau theory—and Denali’s next gen candidate
If Biogen has shown that tau can impact cognition, Denali’s technology—validated with an FDA approval in Hunter syndrome—could ensure the medicine gets where it needs to...
-
Uncategorized4 weeks ago
ASGCT 2026: Beverly Davidson Offers Vehicle and Route for Huntington’s Disease Gene Therapy
ASGCT 2026: Beverly Davidson Offers Vehicle and Route for Huntington’s Disease Gene Therapy
-
Uncategorized4 weeks agoASGCT 2026: Rare Instance of AAV Integration into Human Genome Linked to Brain Tumor
ASGCT 2026: Rare Instance of AAV Integration into Human Genome Linked to Brain Tumor
-
Uncategorized4 weeks ago
M&A isn’t just for big pharma. Mid-size companies are stepping up deal hunts
M&A isn’t just for big pharma. Mid-size companies are stepping up deal hunts
-
Uncategorized4 weeks agoThis week in Drug Discovery (11 – 15 May)
News round-up for 11 – 15 May by Bruno Quinney, Content Team at DDW. This week, research has uncovered new treatment pathways for hard to treat breast cancers. Elsewhere, therapies...
-
Uncategorized4 weeks ago
Future of Aardvark’s Prader-Willi drug in doubt as FDA slaps full hold on program
Aardvark Therapeutics had previously voluntarily suspended studies of ARD-101—and a related asset called ARD-201—after detecting anomalous echocardiographic readings in healthy volunteers that could indicate reduced heart...
-
Uncategorized4 weeks ago
CREATE jumps into CAR T competition with $122M series B
CREATE Medicines is working on a clinical-stage pipeline for cancer, while its autoimmune programs are still in preclinical testing.
-
Uncategorized4 weeks ago
Andrea Pfeifer ends 23-year reign at AC Immune; Acadia’s top R&D exec announces retirement
AC Immune will be searching for a new CEO for the first time, as the company announced this week that Andrea Pfeifer plans to retire after...
-
Uncategorized4 weeks ago
#ASGCT26: A Zillow-like marketplace for abandoned gene therapies goes live
BOSTON — Two nonprofit organizations have devised a plan to help abandoned cell and gene therapies find a new home. On Thursday, the American Society of...
STAT+: Up and down the ladder: The latest comings and goings
FDA imposes import alert on Indian plant after inspectors flag GMP failings
